Walleye Capital LLC Novo Nordisk A S Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $3.06 Million - $3.74 Million	-25,700 Reduced 30.89%	57,500 $6.85 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $4.87 Million - $5.83 Million	-39,700 Reduced 32.3%	83,200 $11.9 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $5.2 Million - $6.92 Million	50,900 Added 70.69%	122,900 $15.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $2.49 Million - $2.99 Million	28,400 Added 65.14%	72,000 $7.45 Million
Q3 2023 Nov 14, 2023	SELL	$90.94 - $199.54 $518,358 - $1.14 Million	-5,700 Reduced 11.56%	43,600 $3.96 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $6.6 Million - $7.3 Million	42,300 Added 604.29%	49,300 $7.98 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $926,380 - $1.11 Million	7,000 New	7,000 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $533,568 - $654,808	5,600 New	5,600 $558,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.